The blood-brain barrier in neuroAIDS
- PMID: 16842079
- DOI: 10.2174/157016206777709447
The blood-brain barrier in neuroAIDS
Abstract
Nearly every aspect of blood-brain barrier (BBB) function is involved in or affected by HIV-1. The disruption of the BBB tends to be minimal and is not likely the mechanism by which infected immune cells and virus enter the brain. Instead, immune cells, virus and viral proteins likely activate brain endothelial cells and enable their own passage across the BBB by way of highly regulated processes such as diapedesis and adsorptive endocytosis. Viral proteins and cytokines can enter the CNS from the blood and provide a mechanism by which HIV-1 can affect CNS function independent of viral transport. Brain endothelial cells can also secrete neuroimmunoactive substances when stimulated by HIV-1, gp120, and Tat. Efflux systems such as p-glycoprotein transport anti-virals in the brain-to-blood direction, thus hampering effective accumulation of drug by the CNS. Overall, the BBB plays a major role in establishing and maintaining virus within the CNS and neuroAIDS.
Similar articles
-
HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells.Brain Res. 2005 May 31;1045(1-2):57-63. doi: 10.1016/j.brainres.2005.03.031. Epub 2005 Apr 19. Brain Res. 2005. PMID: 15910762
-
Physiology and pathology of the blood-brain barrier: implications for microbial pathogenesis, drug delivery and neurodegenerative disorders.J Neurovirol. 1999 Dec;5(6):538-55. doi: 10.3109/13550289909021284. J Neurovirol. 1999. PMID: 10602396 Review.
-
CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS.J Neurosci. 2006 Jan 25;26(4):1098-106. doi: 10.1523/JNEUROSCI.3863-05.2006. J Neurosci. 2006. PMID: 16436595 Free PMC article.
-
Transport of human immunodeficiency virus type 1 pseudoviruses across the blood-brain barrier: role of envelope proteins and adsorptive endocytosis.J Virol. 2001 May;75(10):4681-91. doi: 10.1128/JVI.75.10.4681-4691.2001. J Virol. 2001. PMID: 11312339 Free PMC article.
-
Getting into the brain: Potential of nanotechnology in the management of NeuroAIDS.Adv Drug Deliv Rev. 2016 Aug 1;103:202-217. doi: 10.1016/j.addr.2016.02.008. Epub 2016 Mar 2. Adv Drug Deliv Rev. 2016. PMID: 26944096 Free PMC article. Review.
Cited by
-
Antiretroviral drug-S for a possible HIV elimination.Int J Physiol Pathophysiol Pharmacol. 2019 Aug 15;11(4):149-162. eCollection 2019. Int J Physiol Pathophysiol Pharmacol. 2019. PMID: 31523362 Free PMC article.
-
HIV-1 induces cytoskeletal alterations and Rac1 activation during monocyte-blood-brain barrier interactions: modulatory role of CCR5.Retrovirology. 2014 Feb 26;11:20. doi: 10.1186/1742-4690-11-20. Retrovirology. 2014. PMID: 24571616 Free PMC article.
-
Cytokine signaling modulates blood-brain barrier function.Curr Pharm Des. 2011 Nov;17(33):3729-40. doi: 10.2174/138161211798220918. Curr Pharm Des. 2011. PMID: 21834767 Free PMC article. Review.
-
Caveolin-1 regulates human immunodeficiency virus-1 Tat-induced alterations of tight junction protein expression via modulation of the Ras signaling.J Neurosci. 2008 Jul 30;28(31):7788-96. doi: 10.1523/JNEUROSCI.0061-08.2008. J Neurosci. 2008. PMID: 18667611 Free PMC article.
-
The neuropathogenesis of feline immunodeficiency virus infection: barriers to overcome.Vet J. 2011 Jun;188(3):260-9. doi: 10.1016/j.tvjl.2010.03.022. Epub 2010 Apr 24. Vet J. 2011. PMID: 20418131 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources